当前位置:首页 - 行情中心 - 浙江医药(600216) - 财务分析 - 现金流量表

浙江医药

(600216)

  

流通市值:129.15亿  总市值:129.15亿
流通股本:9.62亿   总股本:9.62亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,152,467,494.588,721,539,348.056,646,605,193.254,145,832,954.45
收到的税费返还221,100,668.61285,978,456.89219,967,162.85140,971,912.22
收到其他与经营活动有关的现金36,945,902.13123,406,697.0895,816,052.6939,216,089.14
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,410,514,065.329,130,924,502.026,962,388,408.794,326,020,955.81
购买商品、接受劳务支付的现金1,103,824,099.44,723,833,724.643,950,848,794.262,510,559,477.02
支付给职工以及为职工支付的现金355,817,531.64985,718,949.68772,633,696.82549,944,427.31
支付的各项税费323,331,597.57638,536,697.14491,762,954.17324,771,252.46
支付其他与经营活动有关的现金322,576,185.711,559,536,488.611,055,082,826.59731,357,620.45
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,105,549,414.327,907,625,860.076,270,328,271.844,116,632,777.24
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额304,964,6511,223,298,641.95692,060,136.95209,388,178.57
二、投资活动产生的现金流量:
收回投资收到的现金196,550,719.59426,771,794.12290,635,061.97221,816,091.38
取得投资收益收到的现金7501,074,717.232,238,856.72704,275.7
处置固定资产、无形资产和其他长期资产收回的现金净额-200,492,312.39193,981,184.07194,836,769.83
收到的其他与投资活动有关的现金276,368,513.26583,369,145.09462,965,740.71273,545,791.11
投资活动现金流入的平衡项目0000
投资活动现金流入小计472,919,982.851,211,707,968.83949,820,843.47690,902,928.02
购建固定资产、无形资产和其他长期资产支付的现金140,229,317.07689,143,769.13473,738,828.29324,104,486.98
投资支付的现金195,436,665.94453,164,069.28291,463,107.44217,903,346.36
支付其他与投资活动有关的现金255,677,242.74542,900,000467,841,795.29316,555,074.15
投资活动现金流出的平衡项目0000
投资活动现金流出小计591,343,225.751,685,207,838.411,233,043,731.02858,562,907.49
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-118,423,242.9-473,499,869.58-283,222,887.55-167,659,979.47
三、筹资活动产生的现金流量:
取得借款收到的现金185,000,000520,000,000485,000,000485,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计185,000,000520,000,000485,000,000485,000,000
偿还债务支付的现金137,000,000573,000,000537,000,000485,000,000
分配股利、利润或偿付利息支付的现金5,771,240.27172,291,361.34165,926,625.8115,436,540.59
其中:子公司支付给少数股东的股利、利润-1,984,887.82--
支付其他与筹资活动有关的现金-30,029,514.9229,367,10629,367,106
筹资活动现金流出平衡项目0000
筹资活动现金流出小计142,771,240.27775,320,876.26732,293,731.81529,803,646.59
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额42,228,759.73-255,320,876.26-247,293,731.81-44,803,646.59
四、汇率变动对现金及现金等价物的影响22,827,650.8311,267,874.7614,146,462.7811,891,286.53
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额251,597,818.66505,745,770.87175,689,980.378,815,839.04
加:期初现金及现金等价物余额1,965,585,411.061,459,839,640.191,459,839,640.191,459,839,640.19
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,217,183,229.721,965,585,411.061,635,529,620.561,468,655,479.23
补充资料:
净利润-1,020,251,510.18-255,365,468.01
资产减值准备-263,898,853.78-67,109,016.06
固定资产和投资性房地产折旧-639,659,876.73-320,121,464.59
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-639,659,876.73-320,121,464.59
无形资产摊销-82,275,878.61-40,973,450.86
长期待摊费用摊销-3,539,035.51-1,295,694.12
处置固定资产、无形资产和其他长期资产的损失--3,090,739.73-958,361.51
固定资产报废损失-8,303,514.39-6,589,467.42
公允价值变动损失-21,534,114.35-11,590,057.79
财务费用-8,584,495.11-1,001,824.81
投资损失-8,069,379.83-11,609,733.51
递延所得税--42,814,569.64-3,133,667.44
其中:递延所得税资产减少--42,814,569.64-3,133,667.44
存货的减少--347,256,415.96--58,490,087.51
经营性应收项目的减少--759,439,761.11--353,681,622.03
经营性应付项目的增加-305,365,146.09--98,308,517.31
其他-13,692,854.83--
现金的期末余额-1,965,585,411.06-1,468,655,479.23
减:现金的期初余额-1,459,839,640.19-1,459,839,640.19
公告日期2025-04-242025-04-242024-10-252024-08-23
审计意见(境内)标准无保留意见
TOP↑